Future perspectives in cardiac rhythm monitoring and smartwatch use
DOI:
https://doi.org/10.32385/rpmgf.v37i6.13077Keywords:
Smartwatch, Monitoring, Remote sensing technologies, Atrial fibrillation, Cardiac arrhythmiasAbstract
The regular use of smartwatches allows monitoring the exercise performed by its users, especially in terms of intensity, duration, energy expenditure, and more recently, heart rate. The potential use of these electronic devices in medicine is an important milestone, allowing through monitoring of cardiac rhythm, a possible way to detect periods of cardiac arrhythmias such as atrial fibrillation and more recently, QT interval prolongation that can cause potentially fatal ventricular arrhythmias, with its importance shown during COVID-19 pandemics. The main studies have several limitations; however, they show the importance of technological evolution and its potential prognostic impact on the users of these devices.
Downloads
References
Monteiro P. Estudo Safira: reflexões sobre a prevalência e os padrões de tratamento de fibrilhação auricular e risco cardiovascular em 7500 indivíduos com 65 ou mais anos [The SAFIRA study: A reflection on the prevalence and treatment patterns of atrial fibrillation and cardiovascular risk factors in 7500 elderly subjects]. Rev Port Cardiol. 2018;37(4):307-13. Portuguese
Perez MV, Mahaffey KW, Hedlin H, Rumsfeld JS, Garcia A, Ferris T, et al. Large-scale assessment of a smartwatch to identify atrial fibrillation. N Engl J Med. 2019;381(20):1909-17.
Campion EW, Jarcho JA. Watched by Apple. N Engl J Med. 2019;381(20):1964-5.
Qiu J, Wang Y. A smartwatch to identify atrial fibrillation. N Engl J Med. 2020;382(10):974-5.
U.S. Food & Drug Administration. Electrocardiograph software for over-the-counter use [homepage]. FDA; 2018 [updated 2021 Sep 20]. Available from:
https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/denovo.cfm?id=DEN180044
Strik M, Caillol T, Ramirez FD, Abu-Alrub S, Marchand H, Welte N, et al. Validating QT-interval measurement using the Apple watch ECG to enable remote monitoring during the COVID-19 pandemic. Circulation. 2020;142(4):416-8.
Downloads
Published
Issue
Section
License
Copyright (c) 2021 Portuguese Journal of Family Medicine and General Practice
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
The authors will assign to the RPMGF the sole right to publish and distribute the content of the manuscript specified in this declaration via physical, electronic, broadcasting or any other medium that may come into existence. They also grant the RPMGF the right to use and exploit this manuscript, in particular by assigning, selling or licensing its content. This permission is permanent and takes effect from the moment the manuscript is submitted, has the maximum duration allowed by applicable Portuguese or international law and is of worldwide scope. The authors further declare that this assignment is made free of charge. If the RPMGF informs the authors that it is not going to publish their manuscript, the exclusive assignment of rights ceases forthwith.
The authors authorise the RPMGF (or any entity it may appoint) to act on their behalf when it believes that copyright may have been infringed.
